Reconstitution of normal and hyperactivated forms of casein kinase-2 by variably mutated beta-subunits

Biochemistry. 1993 Nov 30;32(47):12672-7. doi: 10.1021/bi00210a016.

Abstract

Twenty-one mutants of the noncatalytic beta-subunit of human casein kinase-2 have been created, expressed in Escherichia coli, and purified to homogeneity. They are either modified at the autophosphorylation site (mutants beta delta 1-4 and beta A 5,6) or bear variable deletions in their C-terminal part (mutants beta delta 209-215, beta delta 194-215, beta delta 181-215, beta delta 171-215, beta delta 150-215) or have undergone Ala substitutions for the acidic and basic residues which are concentrated in the sequences 55-70 and 171-180, respectively. All these mutants have been examined for their ability to functionally replace the wild type beta-subunit. All substitutions and the deletions delta 1-4, delta 194-215, and delta 209-215 are compatible with effective binding of the catalytic alpha-subunit, as judged by sucrose density gradient analysis, stimulation of catalytic activity, and protection against thermal denaturation. Deletions delta 171-215 and delta 150-215, however, give rise to truncated molecules which are unable to associate with the alpha-subunit. The intermediate deletion delta 181-215 is still compatible with association, albeit the reconstituted holoenzyme exhibits an altered sedimentation coefficient. The holoenzymes reconstituted with substituted mutants beta A 55,57, beta A55-57, and, to a lesser extent, beta A 59-61, beta A63,64, and beta A5,6 display a basal activity which is higher (up to 4-fold) than that of the wild type holoenzyme.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Casein Kinases
  • Catalysis
  • Cloning, Molecular
  • Enzyme Activation / drug effects
  • Genetic Variation
  • Heparin / pharmacology
  • Humans
  • Kinetics
  • Molecular Sequence Data
  • Mutagenesis
  • Polymerase Chain Reaction
  • Protein Conformation
  • Protein Kinases / drug effects
  • Protein Kinases / genetics*
  • Protein Kinases / metabolism*
  • Sodium Chloride / pharmacology

Substances

  • Sodium Chloride
  • Heparin
  • Protein Kinases
  • Casein Kinases